Kumiko Goto
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cells.
Journal: Cancer immunology, immunotherapy : CII
Published: December 01, 2025
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.
Journal: Stem cell research & therapy
Published: July 08, 2024
Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity.
Journal: Stem cell research & therapy
Published: April 18, 2024
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer.
Journal: Scientific reports
Published: October 18, 2021
The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: March 04, 2020
Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.
Journal: Biological & pharmaceutical bulletin
Published: March 03, 2020
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Journal: International immunology
Published: December 21, 2019
Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Journal: Digestive diseases and sciences
Published: July 29, 2019
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.
Journal: Cancer immunology, immunotherapy : CII
Published: October 21, 2018
Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
Journal: Cancer immunology, immunotherapy : CII
Published: February 03, 2017
Last Updated: 09/26/2026